256 related articles for article (PubMed ID: 15780907)
21. Molecular mechanisms and therapeutic development of angiogenesis inhibitors.
Cao Y
Adv Cancer Res; 2008; 100():113-31. PubMed ID: 18620094
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis and antiangiogenic therapy in hematologic malignancies.
Dong X; Han ZC; Yang R
Crit Rev Oncol Hematol; 2007 May; 62(2):105-18. PubMed ID: 17188504
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
Bikfalvi A
J BUON; 2007 Sep; 12 Suppl 1():S59-66. PubMed ID: 17935279
[TBL] [Abstract][Full Text] [Related]
24. [Tumor angiogenesis].
Bikfalvi A
Bull Cancer; 2003 May; 90(5):449-58. PubMed ID: 12850768
[TBL] [Abstract][Full Text] [Related]
25. Cancer immunotherapy of targeting angiogenesis.
Hou J; Tian L; Wei Y
Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
[TBL] [Abstract][Full Text] [Related]
26. Potential role of vascular targeted therapy to combat against tumor.
Chen B; Jin H; Wu K
Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy.
Shaked Y; Kerbel RS
Cancer Res; 2007 Aug; 67(15):7055-8. PubMed ID: 17671170
[TBL] [Abstract][Full Text] [Related]
28. [Advances in the study of mechanisms of the tumor angiogenesis inhibitors].
Xiao D; Ding J
Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):219-23. PubMed ID: 12532783
[TBL] [Abstract][Full Text] [Related]
29. Novel agents target existing tumor vasculature.
Expert Rev Anticancer Ther; 2010 Mar; 10(3):303. PubMed ID: 20235388
[No Abstract] [Full Text] [Related]
30. [Angiogenic mechanisms in cancer].
Bjerkvig R
Tidsskr Nor Laegeforen; 2000 Nov; 120(29):3501. PubMed ID: 11188372
[No Abstract] [Full Text] [Related]
31. Anti-angiogenic therapy: Prospects for treatment of ocular tumors.
Rosenblatt MI; Azar DT
Semin Ophthalmol; 2006; 21(3):151-60. PubMed ID: 16912013
[TBL] [Abstract][Full Text] [Related]
32. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.
D'Onofrio A; Gandolfi A
Math Med Biol; 2009 Mar; 26(1):63-95. PubMed ID: 19033598
[TBL] [Abstract][Full Text] [Related]
33. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
34. Combining radiotherapy and angiogenesis inhibitors: clinical trial design.
Citrin D; Ménard C; Camphausen K
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):15-25. PubMed ID: 16377411
[TBL] [Abstract][Full Text] [Related]
35. [Angiogenesis and cancer].
Bikfalvi A; Javerzat S; Perollet C; Savona C
Bull Cancer; 1997 Sep; 84(9):885-90. PubMed ID: 9435811
[TBL] [Abstract][Full Text] [Related]
36. Imaging the effects of anti-angiogenic treatments.
Vāvere AL; Lewis JS
Q J Nucl Med; 2003 Sep; 47(3):163-70. PubMed ID: 12897708
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor receptors: expression and function in solid tumors.
Wey JS; Stoeltzing O; Ellis LM
Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
[TBL] [Abstract][Full Text] [Related]
38. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
Crawford Y; Ferrara N
Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
[TBL] [Abstract][Full Text] [Related]
39. Vasculogenic mimicry.
Folberg R; Maniotis AJ
APMIS; 2004; 112(7-8):508-25. PubMed ID: 15563313
[TBL] [Abstract][Full Text] [Related]
40. Antiangiogenic therapy: a universal chemosensitization strategy for cancer?
Kerbel RS
Science; 2006 May; 312(5777):1171-5. PubMed ID: 16728631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
